ICON Public Limited Company

ICON Public Limited Company is a clinical research organization (CRO) that provides outsourced development and commercialization services to pharmaceutical, biotechnology, medical device, government, and public health organizations. The company specializes in strategic development, management, and analysis of programs supporting clinical development from compound selection through Phase I-IV studies. Its services include clinical trial management, consulting, contract staffing, and commercial services such as clinical development strategy, trial design, full study execution, and post-market commercialization. ICON also offers laboratory services like bioanalytical, biomarker, vaccine, GMP, and central lab services. Additionally, it provides adaptive trials, cardiac safety solutions, decentralized and hybrid clinical trials, medical imaging, real-world intelligence, and strategic solutions.

ICON Public Limited Company is listed on the Nasdaq Global Select Market (NasdaqGS) under the ticker symbol ICLR. Its shares are traded in US dollars (USD). The company is headquartered in Ireland and operates globally, but its stock is primarily traded on the US exchange, making it accessible to international investors.

ICON Public Limited Company operates in the Healthcare sector, specifically within the Diagnostics & Research industry. As a clinical research organization, it provides essential research and development services to the healthcare industry, helping clients bring new drugs, devices, and therapies to market. The Diagnostics & Research industry encompasses companies that offer analytical, laboratory, and clinical trial services to support medical advancements.

ICON Public Limited Company is headquartered in Ireland and serves clients globally, including in rest of Europe, the United States, and other international markets. The company's services are utilized by pharmaceutical, biotechnology, and medical device companies, as well as government and public health organizations worldwide. Its global presence allows it to conduct clinical trials and provide laboratory services across multiple regions, leveraging local expertise and regulatory knowledge.

ICON offers a comprehensive portfolio of services including clinical trial management, consulting, contract staffing, and commercial services. Notable offerings include adaptive trials, cardiac safety solutions, decentralized and hybrid clinical trials, early clinical services, laboratory services (bioanalytical, biomarker, vaccine, GMP, central lab), medical imaging, real-world intelligence, and strategic solutions. The company also has a strategic alliance with Advarra, Inc. focused on developing a connected, research-ready clinical trial ecosystem. Additionally, ICON provides full-service and functional service partnerships to customers, supporting all phases of drug development from compound selection to post-market commercialization.